SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-019161
Filing Date
2023-05-09
Accepted
2023-05-09 08:11:55
Documents
14
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rlyb-20230509.htm   iXBRL 8-K 64992
2 EX-99.1 rlyb-ex99_1.htm EX-99 144309
3 GRAPHIC img96626370_0.jpg GRAPHIC 8945
  Complete submission text file 0000950170-23-019161.txt   354852

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20230509_lab.xml EX-101.LAB 13896
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20230509.xsd EX-101.SCH 2452
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20230509_pre.xml EX-101.PRE 11417
8 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20230509_htm.xml XML 4884
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 23900082
SIC: 2834 Pharmaceutical Preparations